CD44-expressing exosomes can bind to SIRPα on the surface of tumor cells without being affected by the tumor clearance system, TP and miR497 inhibit the mTOR signaling pathway, reduce cell metabolism to provide energy and nutrients for tumor cells, and make ovarian cancer cells more sensitive to cisplatin treatment. This evidence concerns the gene SIRPA and neoplasm.